Cicletanine
- Generic Name
- Cicletanine
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C14H12ClNO2
- CAS Number
- 89943-82-8
- Unique Ingredient Identifier
- CHG7QC509W
- Background
Cicletanine is under investigation for the treatment of Diabetes, Hypokalemia, Hyponatremia, and Arterial Hypertension.
- Indication
用于降压。
- Associated Conditions
- -
- Associated Therapies
- -
Cicletanine in Hypertension With Diabetes: Added Magnesium Preserves Potassium and Sodium
Phase 1
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2016-03-15
- Last Posted Date
- 2021-09-05
- Lead Sponsor
- Navitas Pharma
- Target Recruit Count
- 24
- Registration Number
- NCT02709031
Study of Cicletanine for Pulmonary Arterial Hypertension (PAH)
Phase 2
Terminated
- Conditions
- Interventions
- First Posted Date
- 2009-01-30
- Last Posted Date
- 2014-02-04
- Lead Sponsor
- Gilead Sciences
- Target Recruit Count
- 162
- Registration Number
- NCT00832507
- Locations
- 🇺🇸
University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, United States
🇺🇸Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸The Lindner Clinical Trial Center, Cincinnati, Ohio, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath